In the last paragraph of Section 1, the sentence “VDZ is a monoclonal antibody blocking the α4β7 integrin which is selectively expressed by the vascular endothelium in the gastrointestinal tract [7]” should be replaced with: “VDZ is a monoclonal antibody blocking the α4β7 integrin which is selectively expressed by the activated GUT homing lymphocytes [7]”. Mariabeatrice Principi, Gastroenterology Section, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy, should have been listed in Appendix A (Members of the GIVI Study Group).
Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” (Dig. Liver Dis. (2016) 48(4) (360–370)) / A. Armuzzi, P. Gionchetti, M. Daperno, S. Danese, A. Orlando, M.L. Scribano, M. Vecchi, F. Rizzello, S. Ardizzone, F. Castiglione, M. Fantini, G. Fiorino, G. Frieri, L. Neri, M. Principi, G.C. Sturniolo. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 48:9(2016 Sep), pp. 1103-1103.
Titolo: | Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” (Dig. Liver Dis. (2016) 48(4) (360–370)) |
Autori: | |
Parole Chiave: | Hepatology; Gastroenterology |
Settore Scientifico Disciplinare: | Settore MED/12 - Gastroenterologia |
Data di pubblicazione: | set-2016 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.dld.2016.06.015 |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
1-s2.0-S1590865816304741.pdf | Publisher's version/PDF | Administrator Richiedi una copia |